Prednisolone dose-dependently influences inflammation and coagulation during human endotoxemia

The effects of steroids on the outcome of sepsis are dose dependent. Low doses appear to be beneficial, but high doses do not improve outcome for reasons that are insufficiently understood. The effects of steroids on systemic inflammation as a function of dose have not previously been studied in hum...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of Immunology Vol. 178; no. 3; pp. 1845 - 1851
Main Authors:	de Kruif, Martijn D, Lemaire, Lucienne C, Giebelen, Ida A, van Zoelen, Marieke A D, Pater, Jennie M, van den Pangaart, Petra S, Groot, Angelique P, de Vos, Alex F, Elliott, Peter J, Meijers, Joost C M, Levi, Marcel, van der Poll, Tom
Format:	Journal Article
Language:	English
Published:	United States 01.02.2007
Subjects:	Adult Biomarkers - blood Blood Coagulation - drug effects Chemokines - blood Cytokines - blood Cytokines - drug effects Dose-Response Relationship, Drug Endothelial Cells - drug effects Endotoxemia - drug therapy Endotoxemia - pathology Escherichia coli Fibrinolysis - drug effects Humans Inflammation - drug therapy Lipopolysaccharides - administration & dosage Male Neutrophil Activation - drug effects Prednisolone - administration & dosage Prednisolone - pharmacology
ISSN:	0022-1767, 1365-2567
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	The effects of steroids on the outcome of sepsis are dose dependent. Low doses appear to be beneficial, but high doses do not improve outcome for reasons that are insufficiently understood. The effects of steroids on systemic inflammation as a function of dose have not previously been studied in humans. To determine the effects of increasing doses of prednisolone on inflammation and coagulation in humans exposed to LPS, 32 healthy males received prednisolone orally at doses of 0, 3, 10, or 30 mg (n = 8 per group) at 2 h before i.v. injection of Escherichia coli LPS (4 ng/kg). Prednisolone dose-dependently inhibited the LPS-induced release of cytokines (TNF-alpha and IL-6) and chemokines (IL-8 and MCP-1), while enhancing the release of the anti-inflammatory cytokine IL-10. Prednisolone attenuated neutrophil activation (plasma elastase levels) and endothelial cell activation (von Willebrand factor). Most remarkably, prednisolone did not inhibit LPS-induced coagulation activation, measured by plasma concentrations of thrombin-antithrombin complexes, prothrombin fragment F1+2, and soluble tissue factor. In addition, activation of the fibrinolytic pathway (tissue-type plasminogen activator and plasmin-alpha(2)-antiplasmin complexes) was dose-dependently enhanced by prednisolone. These data indicate that prednisolone dose-dependently and differentially influences the systemic activation of different host response pathways during human endotoxemia.
AbstractList	The effects of steroids on the outcome of sepsis are dose dependent. Low doses appear to be beneficial, but high doses do not improve outcome for reasons that are insufficiently understood. The effects of steroids on systemic inflammation as a function of dose have not previously been studied in humans. To determine the effects of increasing doses of prednisolone on inflammation and coagulation in humans exposed to LPS, 32 healthy males received prednisolone orally at doses of 0, 3, 10, or 30 mg (n = 8 per group) at 2 h before i.v. injection of Escherichia coli LPS (4 ng/kg). Prednisolone dose-dependently inhibited the LPS-induced release of cytokines (TNF-alpha and IL-6) and chemokines (IL-8 and MCP-1), while enhancing the release of the anti-inflammatory cytokine IL-10. Prednisolone attenuated neutrophil activation (plasma elastase levels) and endothelial cell activation (von Willebrand factor). Most remarkably, prednisolone did not inhibit LPS-induced coagulation activation, measured by plasma concentrations of thrombin-antithrombin complexes, prothrombin fragment F1+2, and soluble tissue factor. In addition, activation of the fibrinolytic pathway (tissue-type plasminogen activator and plasmin-alpha(2)-antiplasmin complexes) was dose-dependently enhanced by prednisolone. These data indicate that prednisolone dose-dependently and differentially influences the systemic activation of different host response pathways during human endotoxemia.The effects of steroids on the outcome of sepsis are dose dependent. Low doses appear to be beneficial, but high doses do not improve outcome for reasons that are insufficiently understood. The effects of steroids on systemic inflammation as a function of dose have not previously been studied in humans. To determine the effects of increasing doses of prednisolone on inflammation and coagulation in humans exposed to LPS, 32 healthy males received prednisolone orally at doses of 0, 3, 10, or 30 mg (n = 8 per group) at 2 h before i.v. injection of Escherichia coli LPS (4 ng/kg). Prednisolone dose-dependently inhibited the LPS-induced release of cytokines (TNF-alpha and IL-6) and chemokines (IL-8 and MCP-1), while enhancing the release of the anti-inflammatory cytokine IL-10. Prednisolone attenuated neutrophil activation (plasma elastase levels) and endothelial cell activation (von Willebrand factor). Most remarkably, prednisolone did not inhibit LPS-induced coagulation activation, measured by plasma concentrations of thrombin-antithrombin complexes, prothrombin fragment F1+2, and soluble tissue factor. In addition, activation of the fibrinolytic pathway (tissue-type plasminogen activator and plasmin-alpha(2)-antiplasmin complexes) was dose-dependently enhanced by prednisolone. These data indicate that prednisolone dose-dependently and differentially influences the systemic activation of different host response pathways during human endotoxemia. The effects of steroids on the outcome of sepsis are dose dependent. Low doses appear to be beneficial, but high doses do not improve outcome for reasons that are insufficiently understood. The effects of steroids on systemic inflammation as a function of dose have not previously been studied in humans. To determine the effects of increasing doses of prednisolone on inflammation and coagulation in humans exposed to LPS, 32 healthy males received prednisolone orally at doses of 0, 3, 10, or 30 mg (n = 8 per group) at 2 h before i.v. injection of Escherichia coli LPS (4 ng/kg). Prednisolone dose-dependently inhibited the LPS-induced release of cytokines (TNF-alpha and IL-6) and chemokines (IL-8 and MCP-1), while enhancing the release of the anti-inflammatory cytokine IL-10. Prednisolone attenuated neutrophil activation (plasma elastase levels) and endothelial cell activation (von Willebrand factor). Most remarkably, prednisolone did not inhibit LPS-induced coagulation activation, measured by plasma concentrations of thrombin-antithrombin complexes, prothrombin fragment F1+2, and soluble tissue factor. In addition, activation of the fibrinolytic pathway (tissue-type plasminogen activator and plasmin-alpha(2)-antiplasmin complexes) was dose-dependently enhanced by prednisolone. These data indicate that prednisolone dose-dependently and differentially influences the systemic activation of different host response pathways during human endotoxemia. The effects of steroids on the outcome of sepsis are dose dependent. Low doses appear to be beneficial, but high doses do not improve outcome for reasons that are insufficiently understood. The effects of steroids on systemic inflammation as a function of dose have not previously been studied in humans. To determine the effects of increasing doses of prednisolone on inflammation and coagulation in humans exposed to LPS, 32 healthy males received prednisolone orally at doses of 0, 3, 10, or 30 mg (n = 8 per group) at 2 h before i.v. injection of Escherichia coli LPS (4 ng/kg). Prednisolone dose-dependently inhibited the LPS-induced release of cytokines (TNF- alpha and IL-6) and chemokines (IL-8 and MCP-1), while enhancing the release of the anti-inflammatory cytokine IL-10. Prednisolone attenuated neutrophil activation (plasma elastase levels) and endothelial cell activation (von Willebrand factor). Most remarkably, prednisolone did not inhibit LPS-induced coagulation activation, measured by plasma concentrations of thrombin-antithrombin complexes, prothrombin fragment F1+2, and soluble tissue factor. In addition, activation of the fibrinolytic pathway (tissue-type plasminogen activator and plasmin- alpha sub(2)-antiplasmin complexes) was dose-dependently enhanced by prednisolone. These data indicate that prednisolone dose-dependently and differentially influences the systemic activation of different host response pathways during human endotoxemia.
Author	Elliott, Peter J Levi, Marcel Lemaire, Lucienne C van Zoelen, Marieke A D de Kruif, Martijn D Giebelen, Ida A de Vos, Alex F van der Poll, Tom Pater, Jennie M van den Pangaart, Petra S Groot, Angelique P Meijers, Joost C M
Author_xml	– sequence: 1 givenname: Martijn D surname: de Kruif fullname: de Kruif, Martijn D email: m.d.dekruif@amc.uva.nl organization: Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. m.d.dekruif@amc.uva.nl – sequence: 2 givenname: Lucienne C surname: Lemaire fullname: Lemaire, Lucienne C – sequence: 3 givenname: Ida A surname: Giebelen fullname: Giebelen, Ida A – sequence: 4 givenname: Marieke A D surname: van Zoelen fullname: van Zoelen, Marieke A D – sequence: 5 givenname: Jennie M surname: Pater fullname: Pater, Jennie M – sequence: 6 givenname: Petra S surname: van den Pangaart fullname: van den Pangaart, Petra S – sequence: 7 givenname: Angelique P surname: Groot fullname: Groot, Angelique P – sequence: 8 givenname: Alex F surname: de Vos fullname: de Vos, Alex F – sequence: 9 givenname: Peter J surname: Elliott fullname: Elliott, Peter J – sequence: 10 givenname: Joost C M surname: Meijers fullname: Meijers, Joost C M – sequence: 11 givenname: Marcel surname: Levi fullname: Levi, Marcel – sequence: 12 givenname: Tom surname: van der Poll fullname: van der Poll, Tom
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/17237435$$D View this record in MEDLINE/PubMed
BookMark	eNqFkMlOwzAYhC1URBd4AiSUE7cEb7GTI6rYpEpwgCuRE_8prryUOJbo21NoOXOaGembOcwcTXzwgNAlwQXHvL7ZGOeSD7YgsipYQSpenqAZYaLMaSnkBM0wpjQnUsgpmse4wRgLTPkZmhJJmeSsnKH3lwG0NzHY_XimQ4Rcwxa8Bj_aXWZ8bxP4DuKvVc6p0QSfKa-zLqh1soes02D8OvtITvls3w5j-AJn1Dk67ZWNcHHUBXq7v3tdPuar54en5e0q77iUY66ZVL2mGne9FgKoquqWaCyF0DWHvme16rGiouxaVVclF0y1XAuN246ysqZsga4Pu9shfCaIY-NM7MBa5SGk2Iiq5owQ_C9IallVnP6AV0cwtQ50sx2MU8Ou-buOfQO3MHcO
CitedBy_id	crossref_primary_10_1515_jpm_2025_0116 crossref_primary_10_1016_j_jinf_2009_11_010 crossref_primary_10_1002_cpt_2516 crossref_primary_10_1097_00003246_200910000_00008 crossref_primary_10_3389_fimmu_2016_00592 crossref_primary_10_1177_20406223221125683 crossref_primary_10_1186_s12931_022_02060_3 crossref_primary_10_1111_j_1538_7836_2010_04034_x crossref_primary_10_1002_ajh_24785 crossref_primary_10_1111_j_1600_6143_2009_02675_x crossref_primary_10_1182_bloodadvances_2023011937 crossref_primary_10_3389_fimmu_2023_1075066 crossref_primary_10_4049_jimmunol_0802189 crossref_primary_10_1097_SHK_0b013e3181598a6a crossref_primary_10_1111_jth_13493 crossref_primary_10_1146_annurev_physiol_061121_040214 crossref_primary_10_1177_0885066618803062 crossref_primary_10_1007_s12630_020_01814_1 crossref_primary_10_1073_pnas_2024852118 crossref_primary_10_1136_lupus_2022_000799 crossref_primary_10_1161_ATVBAHA_122_318179 crossref_primary_10_1183_13993003_01298_2019 crossref_primary_10_3389_fmicb_2018_02968 crossref_primary_10_1016_j_imlet_2008_09_005 crossref_primary_10_1155_2017_5620314 crossref_primary_10_1016_j_phrs_2017_09_006 crossref_primary_10_1186_s13049_019_0596_4 crossref_primary_10_1016_j_lpm_2012_01_009 crossref_primary_10_1109_JBHI_2020_2986183 crossref_primary_10_3109_00498250903189454 crossref_primary_10_1161_ATVBAHA_114_304455 crossref_primary_10_3390_ijms24087278 crossref_primary_10_3390_insects12040297 crossref_primary_10_1111_jth_13504 crossref_primary_10_1111_j_1538_7836_2012_04733_x crossref_primary_10_1177_0148607113518945 crossref_primary_10_1177_039463201302600404 crossref_primary_10_1371_journal_pone_0263968 crossref_primary_10_3390_jcm8040478 crossref_primary_10_2478_aite_2024_0011 crossref_primary_10_1177_0968051907085986 crossref_primary_10_1016_j_athoracsur_2013_06_012 crossref_primary_10_1097_INF_0000000000003260 crossref_primary_10_1097_SHK_0b013e3182168d56 crossref_primary_10_1097_SHK_0b013e31817d423a crossref_primary_10_1016_j_neuint_2010_12_020 crossref_primary_10_1016_j_atherosclerosis_2019_02_007 crossref_primary_10_1016_j_micpath_2018_02_043 crossref_primary_10_1016_j_ddmod_2011_07_007 crossref_primary_10_1111_bcp_12857 crossref_primary_10_1016_j_chest_2017_07_014 crossref_primary_10_1177_0884533611434934 crossref_primary_10_7759_cureus_21571 crossref_primary_10_1097_CCM_0b013e3181a592b3 crossref_primary_10_1097_MBC_0b013e328346ef3f crossref_primary_10_3390_ijms22147734 crossref_primary_10_1016_j_jsbmb_2009_05_001 crossref_primary_10_1080_23744235_2020_1718200 crossref_primary_10_1160_TH14_09_0731 crossref_primary_10_1007_s12288_019_01239_x crossref_primary_10_1097_SHK_0000000000000930 crossref_primary_10_1007_s00134_007_0955_x crossref_primary_10_1097_01_CCM_0000297875_55969_DB crossref_primary_10_1007_s00134_007_0956_9 crossref_primary_10_1016_j_biochi_2018_06_014 crossref_primary_10_1016_j_jcrc_2017_04_015 crossref_primary_10_1186_cc9182 crossref_primary_10_3389_fimmu_2019_00085 crossref_primary_10_1111_cts_13771 crossref_primary_10_1016_j_trsl_2007_05_003 crossref_primary_10_3389_fmed_2022_856891 crossref_primary_10_1177_1753425909339923 crossref_primary_10_1080_17474086_2023_2288154 crossref_primary_10_1210_jc_2017_00696 crossref_primary_10_1182_blood_2008_08_172767 crossref_primary_10_1182_blood_2010_12_325951 crossref_primary_10_1177_0968051907086465 crossref_primary_10_1002_14651858_CD002243_pub5 crossref_primary_10_1155_2022_3144685 crossref_primary_10_1177_08850666251353723
ContentType	Journal Article
DBID	CGR CUY CVF ECM EIF NPM 7QL 7T5 C1K H94 7X8
DOI	10.4049/jimmunol.178.3.1845
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Immunology Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Immunology Abstracts Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE AIDS and Cancer Research Abstracts
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine Biology
EISSN	1365-2567
EndPage	1851
ExternalDocumentID	17237435
Genre	Clinical Trial Research Support, Non-U.S. Gov't Journal Article
GroupedDBID	--- -~X .55 18M 2WC 34G 39C 3O- 53G 5GY 5RE 5VS 5WD 79B 85S AARDX ABCQX ABDFA ABEFU ABGNP ABJNI ABOCM ABPPZ ACGFO ACGFS ACIWK ACNCT ACPRK ADBBV ADIPN ADNWM AENEX AFFNX AFHIN AFOSN AFRAH AHMMS AHWXS AIZAD ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CGR CUY CVF D0L DIK DU5 E3Z EBS ECM EIF EJD F5P FRP GX1 H13 IH2 J5H K-O KQ8 L7B MVM NEJ NPM OCZFY OK1 OWPYF P0W P2P PQQKQ R.V RHF RHI ROX RZQ SJN TR2 TWZ VXZ W8F WH7 WOQ X7M XJT XSW XTH YHG YIN ZE2 ZGI .3N .GA .Y3 05W 0R~ 10A 1OC 29I 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 5HH 5LA 66C 702 7PT 7QL 7T5 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 A8Z AAESR AAEVG AAFWJ AAHQN AAIPD AAMMB AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABPVW ABQWH ABXGK ACAHQ ACCZN ACGOF ACMXC ACPOU ACUHS ACXBN ACXQS ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEFGJ AEGXH AEIGN AEIMD AEUYR AEYWJ AFBPY AFEBI AFFPM AFGKR AFWVQ AFZJQ AGXDD AGYGG AHBTC AIACR AIAGR AIDQK AIDYY AITYG AIURR ALAGY ALUQN ALVPJ AMBMR AMYDB AOIJS ATUGU AZBYB AZVAB BAFTC BFHJK BHBCM BMXJE BROTX BRXPI BY8 C1K C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM EAD EAP EAS EBB EBC EBD EBX EMB EMK EMOBN EPT ESTFP ESX EX3 F00 F01 F04 FD6 FIJ FUBAC G-S G.N GODZA H.X H94 HGLYW HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OBC OBS OIG OVD P2W P2X P2Z P4B P4D Q.N Q11 QB0 Q~Q R.K ROL RPM RX1 SUPJJ SV3 TEORI TUS UB1 UPT V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WVDHM WXI WXSBR XG1 YF5 YFH YOC YUY ZZTAW ~IA ~KM ~WT 7X8 ABEJV ABXVV ADXHL AETEA ARBBW BCRHZ KOP
ID	FETCH-LOGICAL-c477t-d37afd2d0cfd66e2a89b1d0766d94eff39af0a265cba985463ab4d6d0bc235923
ISICitedReferencesCount	92
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000243820900070&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0022-1767
IngestDate	Sat Sep 27 19:39:44 EDT 2025 Tue Oct 07 09:18:58 EDT 2025 Wed Feb 19 02:33:01 EST 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	3
Language	English
LinkModel	OpenURL
MergedId	FETCHMERGED-LOGICAL-c477t-d37afd2d0cfd66e2a89b1d0766d94eff39af0a265cba985463ab4d6d0bc235923
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1
OpenAccessLink	https://journals.aai.org/jimmunol/article-pdf/178/3/1845/1234978/zim00307001845.pdf
PMID	17237435
PQID	19788420
PQPubID	23462
PageCount	7
ParticipantIDs	proquest_miscellaneous_68943110 proquest_miscellaneous_19788420 pubmed_primary_17237435
PublicationCentury	2000
PublicationDate	2007-Feb-01 20070201
PublicationDateYYYYMMDD	2007-02-01
PublicationDate_xml	– month: 02 year: 2007 text: 2007-Feb-01 day: 01
PublicationDecade	2000
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Journal of Immunology
PublicationTitleAlternate	J Immunol
PublicationYear	2007
SSID	ssj0006024 ssj0013055
Score	2.2102964
Snippet	The effects of steroids on the outcome of sepsis are dose dependent. Low doses appear to be beneficial, but high doses do not improve outcome for reasons that...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	1845
SubjectTerms	Adult Biomarkers - blood Blood Coagulation - drug effects Chemokines - blood Cytokines - blood Cytokines - drug effects Dose-Response Relationship, Drug Endothelial Cells - drug effects Endotoxemia - drug therapy Endotoxemia - pathology Escherichia coli Fibrinolysis - drug effects Humans Inflammation - drug therapy Lipopolysaccharides - administration & dosage Male Neutrophil Activation - drug effects Prednisolone - administration & dosage Prednisolone - pharmacology
Title	Prednisolone dose-dependently influences inflammation and coagulation during human endotoxemia
URI	https://www.ncbi.nlm.nih.gov/pubmed/17237435 https://www.proquest.com/docview/19788420 https://www.proquest.com/docview/68943110
Volume	178
WOSCitedRecordID	wos000243820900070&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVWIB databaseName: Wiley Online Library - Journals customDbUrl: eissn: 1365-2567 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0013055 issn: 0022-1767 databaseCode: DRFUL dateStart: 19960101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 1365-2567 dateEnd: 20241209 omitProxy: false ssIdentifier: ssj0013055 issn: 0022-1767 databaseCode: WIN dateStart: 19960101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Lb9MwGLe6ARMXBAPGeIwcELeUJHb8OKKtg0pt6aETFQciJ3ZQoE1KH1P3J_Ff8jlOloBWAQcuVuSmruvvp-_l74HQK4KN2FHY5VJzl8SUuAInvotlGmtBwMigZaLwgI1GfDoV407nR50Lczljec63W7H4r6SGOSC2SZ39B3JfLwoT8AxEhxHIDuNfEX681CrP4DcK0B_PipV2z6pGt-vZFfCDqinJqnyUc5u6WN4hnBbyS9XNq05ftD7-Xg62a7HV80zuUGb7Js3kFw-90sBANllaJQSts695E1080HNZOcUHm6SMOWvcte8yIPnMssO-ko231aRafSrqj4bGyv-m64KSteeC1cHOaTuTwGe2HUdXWwZcRt2F1VzNoRlvQRG3-C3Yp2FLdoPy4d8kFwjYQUYuZPYwurBgF3ebL7ercI8-ROcXg0E06U0nrxffXdOgzFzkV91a9tCtgIXCRA9-7I-uhT71TJZNfXvlhWFdpd78P1vtymzizQ1b2G3blDrO5D66V9HTeWtB9QB1dH6I7th2pVeH6GBYBWI8RJ_bKHN-R5nToMxpo8wBlDktlDkWZU6JMqeFskfo4rw3OX3vVq063IQwtnYVZjJVgfKSVFGqA8lF7CuPUaoE0WmKhUw9GdAwiaXgpgWDjImiyouTAIdgZDxG-zls-AlyUsFZEAKjwDEhMbwPCqemKaGx5poTfoxe1scVASs091sy18VmFfmCcU4Cb_cb1HQbAIX3GB3Zc44WtqZLBHo8BmU6fPrH1Z-huw2Yn6P99XKjX6DbyeU6Wy1P0B6bchhH4-FJiZCfp6WYOQ
linkProvider	Wiley-Blackwell
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prednisolone+Dose-Dependently+Influences+Inflammation+and+Coagulation+during+Human+Endotoxemia&rft.jtitle=Journal+of+Immunology&rft.au=de+Kruif%2C+Martijn+D&rft.au=Lemaire%2C+Lucienne+C&rft.au=Giebelen%2C+Ida+A&rft.au=van+Zoelen%2C+Marieke+AD&rft.date=2007-02-01&rft.issn=0022-1767&rft.eissn=1365-2567&rft.volume=178&rft.issue=3&rft.spage=1845&rft.epage=1851&rft_id=info:doi/10.4049%2Fjimmunol.178.3.1845&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon